Member Info for gixer

Yes I did see that DP64 and thought it was a bit cheeky.

Fruitflow is a registered trademark of Provexis and always has been.

DSM were or maybe still are allowed to use the trademark under licence.

I would assume this product falls under the Premix and Market-Ready Solutions supply agreement with DSM.

BWTFDIK.

Yes.

Probably more than "a single penny" but not as much as when By-Health get the "new permitted health function claim"

"it is currently expected that this would result in some significant orders for Fruitflow, potentially at a multiple of current total sales values."

From Japan this time.

https://shop.fmg-mission.jp/products/?id=ZA0005179

Some big delayed trades starting to show now.

It's your choice Xpub but I wouldn't like to think what selling 30 million shares would do to the sp atm.

Dropping the price for no good reason unless there is a massive delayed sell today.

Hope it's not an open offer at this price. Loan finance please :)

Looks like H&B are just slow at reordering then?????

Circu Health From Nutrimax

https://nutrimax.co.id/product/circu-health-nutrimax-30-tablet-selaput/

I would put it more like this.

products are finished and ready for manufacture and market, just waiting for those approvals.

But as I say, just a guess.

I assumed that "product reserves" related to knowing what specific ff products they will launch once they have approvals.

But that's nothing more than a guess.

"according to industry policies and the application and approval of new functions of health food."

2 things outside of By-Health s control.

By-Health investors relations.

Investors asked BY-HEALTH (300146) :

According to previous news reports, BY-HEALTH was preparing to promote the product of Qingluosu in 2016, and published some related articles every once in a while. May I ask why the company has not launched related products for so many years.

2023-05-11 00:03:53

BY-HEALTH (300146) replied to investors :

Hello investors! The company has done relevant research and development and product reserves, and will launch new products in due course according to industry policies and the application and approval of new functions of health food. Thanks for attention. (From: Shenzhen Stock Exchange Interactive Trading)

2023-05-17 17:05:42

https://ir.p5w.net/question/0001EA50C495E01B4554B7097DFA5EC1D2CE.shtml

Nice to see that the products now say.

"Fruitflow® is a trade mark used under license from Provexis plc."

Instead of the usual

"Fruitflow® is a trademark used under license by DSM"

although I assume the later will still be used on products from the Premix and Market-Ready Solutions supply agreement with DSM.

Not 1 but 2 this time.

FRUITFLOW

TOMATEN EXTRAKT

https://www.sunday.de/fruitflow-kapseln.html

CARDIO FLOW

https://www.sunday.de/cardio-flow-kapseln.html

Https://fb.watch/kxQH_OCLld/

Small mention in this review article.

Department of Cardiology, The Second Hospital of Jilin University, Changchun, China.

The tomato extract Fruitflow® restored collagen-activated platelet cyclic AMP levels, reduced collagen-induced phosphorylation of protein kinase A substrates, and reduced platelet AKT, glycogen synthase kinase 3β, p38 MAPK, and HSP27 phosphorylation, which is beneficial in people at risk of platelet hyperactivity-induced thrombosis

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1195464/full

He also said, 'Now the trial has started at Chettinath Medical University in Chennai, India.

https://kalbela.com/ajkerpatrika/lastpage/tuymwkotei?fbclid=IwAR3spF9l_cAtr6yApMDpTCA-keqdTH6s0467tTbtnQ94vBuDnlovDJu5_sA

To be honest I don't remember.
Need to look back.

Taiwan
Aesthetic Medicine World Congress ASIA & Taiwan Dermatology Aesthetic Conference 2023

Sunday, 7 May 2023
Anti-aging in the era of aesthetics
SESSION PRESENTATION
Studies on Anti-aging and cardioprotective effect of tomato extract (FruitFlow®) on cardiomyoblast cells H9C2 (2-1)
Surajit PATHAK
https://agenda.euromedicom.com/global/o/amwc-asia-2023/2023-05-07/6400

Surajit PATHAK
Biologist / Biochemist
INDIA

Dr. Surajit Pathak is an Indian-born research scientist, advisor, and Professor at CHETTINAD ACADEMY OF RESEARCH AND EDUCATION, Chennai who has multiple expertise encompassing cancer biology, stem cell, and regenerative medicine. He started active research in the year 2001 and received his Ph.D. from INDIA in 2007. Worked in USA, Italy, and Sweden for over 10 years with 1800 citations. Dr. Pathak has published over 120 papers to date.
https://agenda.euromedicom.com/global/o/amwc-asia-2023/speaker/95093-pathak-surajit
https://www.linkedin.com/in/dr-surajit-pathak-3483972a/?originalSubdomain=in

He has contributed on published articles that include Fruitflow.
Bioactive food components and their inhibitory actions in multiple platelet pathways
https://onlinelibrary.wiley.com/doi/10.1111/jfbc.14476

I did wonder lol.